Table 3.
Performance of the selected models on immune-related adverse event extraction, measured by macro-average F1-score with 95% CI. Higher values indicate better performance.
| Category | Mistral-small | Phi4 | Meditron3-Phi4 | Falcon3 | Llama3.1 | Meditron3 |
| Cardiac | 0.36 | 0.33 | 0.40 | 0.31 | 0.00 | 0.40 |
| Colitis | 0.46 | 0.54 | 0.53 | 0.44 | 0.54 | 0.45 |
| Diabetes | 0.25 | 0.55 | 0.17 | 0.00 | 0.00 | 0.00 |
| Hepatitis | 0.38 | 0.36 | 0.33 | 0.29 | 0.18 | 0.09 |
| Hypophysitis | 0.31 | 0.32 | 0.31 | 0.12 | 0.12 | 0.17 |
| Nephrological | 0.08 | 0.22 | 0.35 | 0.24 | 0.21 | 0.29 |
| Neurological | 0.08 | 0.11 | 0.11 | 0.03 | 0.06 | 0.00 |
| Pancreatitis | 0.55 | 0.67 | 0.00 | 0.57 | 0.67 | 0.40 |
| Pneumonitis | 0.46 | 0.53 | 0.43 | 0.29 | 0.22 | 0.00 |
| Rheumatological | 0.07 | 0.09 | 0.08 | 0.00 | 0.00 | 0.00 |
| Skin | 0.21 | 0.20 | 0.26 | 0.18 | 0.29 | 0.18 |
| Thyroiditis | 0.30 | 0.34 | 0.29 | 0.31 | 0.24 | 0.14 |
| Overall (95% CI) | 0.29 (0.20-0.35) | 0.35 (0.25-0.42) | 0.26 (0.19-0.32) | 0.23 (0.15-0.28) | 0.21 (0.12-0.26) | 0.17 (0.08-0.25) |